This invention relates to a method of inhibiting the expression of
TNF.alpha. or IL-1.beta. with a compound of the following formula: 1
wherein R.sub.1 and R.sub.2 are defined herein. It also relates to is a
method of treating inflammatory bowel disease with such a compound.